Literature DB >> 17053143

Molecular imaging using a targeted magnetic resonance hyperpolarized biosensor.

Leif Schröder1, Thomas J Lowery, Christian Hilty, David E Wemmer, Alexander Pines.   

Abstract

A magnetic resonance approach is presented that enables high-sensitivity, high-contrast molecular imaging by exploiting xenon biosensors. These sensors link xenon atoms to specific biomolecular targets, coupling the high sensitivity of hyperpolarized nuclei with the specificity of biochemical interactions. We demonstrated spatial resolution of a specific target protein in vitro at micromolar concentration, with a readout scheme that reduces the required acquisition time by >3300-fold relative to direct detection. This technique uses the signal of free hyperpolarized xenon to dramatically amplify the sensor signal via chemical exchange saturation transfer (CEST). Because it is approximately 10,000 times more sensitive than previous CEST methods and other molecular magnetic resonance imaging techniques, it marks a critical step toward the application of xenon biosensors as selective contrast agents in biomedical applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17053143     DOI: 10.1126/science.1131847

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  114 in total

1.  Cell-compatible, integrin-targeted cryptophane-129Xe NMR biosensors.

Authors:  Garry K Seward; Yubin Bai; Najat S Khan; Ivan J Dmochowski
Journal:  Chem Sci       Date:  2011-06       Impact factor: 9.825

Review 2.  Dynamic nuclear polarization at high magnetic fields.

Authors:  Thorsten Maly; Galia T Debelouchina; Vikram S Bajaj; Kan-Nian Hu; Chan-Gyu Joo; Melody L Mak-Jurkauskas; Jagadishwar R Sirigiri; Patrick C A van der Wel; Judith Herzfeld; Richard J Temkin; Robert G Griffin
Journal:  J Chem Phys       Date:  2008-02-07       Impact factor: 3.488

Review 3.  Chemical exchange saturation transfer contrast agents for magnetic resonance imaging.

Authors:  A Dean Sherry; Mark Woods
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

4.  Near-unity nuclear polarization with an open-source 129Xe hyperpolarizer for NMR and MRI.

Authors:  Panayiotis Nikolaou; Aaron M Coffey; Laura L Walkup; Brogan M Gust; Nicholas Whiting; Hayley Newton; Scott Barcus; Iga Muradyan; Mikayel Dabaghyan; Gregory D Moroz; Matthew S Rosen; Samuel Patz; Michael J Barlow; Eduard Y Chekmenev; Boyd M Goodson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-14       Impact factor: 11.205

Review 5.  Sensitivity enhancement in solution NMR: emerging ideas and new frontiers.

Authors:  Jung Ho Lee; Yusuke Okuno; Silvia Cavagnero
Journal:  J Magn Reson       Date:  2014-04       Impact factor: 2.229

6.  Substituent effects on xenon binding affinity and solution behavior of water-soluble cryptophanes.

Authors:  P Aru Hill; Qian Wei; Thomas Troxler; Ivan J Dmochowski
Journal:  J Am Chem Soc       Date:  2009-03-04       Impact factor: 15.419

7.  Anthranilic acid analogs as diamagnetic CEST MRI contrast agents that feature an intramolecular-bond shifted hydrogen.

Authors:  Xiaolei Song; Xing Yang; Sangeeta Ray Banerjee; Martin G Pomper; Michael T McMahon
Journal:  Contrast Media Mol Imaging       Date:  2014-04-28       Impact factor: 3.161

Review 8.  Proteins, air and water: reporter genes for ultrasound and magnetic resonance imaging.

Authors:  George J Lu; Arash Farhadi; Arnab Mukherjee; Mikhail G Shapiro
Journal:  Curr Opin Chem Biol       Date:  2018-03-14       Impact factor: 8.822

9.  Cryptophane xenon-129 nuclear magnetic resonance biosensors targeting human carbonic anhydrase.

Authors:  Jennifer M Chambers; P Aru Hill; Julie A Aaron; Zhaohui Han; David W Christianson; Nicholas N Kuzma; Ivan J Dmochowski
Journal:  J Am Chem Soc       Date:  2009-01-21       Impact factor: 15.419

Review 10.  Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers.

Authors:  Jessica Wahsner; Eric M Gale; Aurora Rodríguez-Rodríguez; Peter Caravan
Journal:  Chem Rev       Date:  2018-10-16       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.